Valeant Pharmaceuticals Intl (VRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRX | CRNX | STVN | ||
| Company | Valeant Pharmaceuticals Intl | Crinetics Pharmaceuticals Inc | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 24.15 | 84.96 | 20.64 | ||
| High | 24.43 | 85.01 | 21.23 | ||
| Low | 23.36 | 84.92 | 20.61 | ||
| Last | 23.40 | 84.95 | 20.50 | ||
| Change | -0.83 | +0.11 | -0.21 | ||
| Percent Change | -3.43% | +0.13% | -1.01% | ||
| Volume | 6,569,300 | 8,208,400 | 94,398 | ||
| 20-Day Average Volume | 6,685,200 | 2,566,585 | 439,970 | ||
| Previous | 24.23 | 84.84 | 20.71 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.73 | 84.53 | 21.43 | ||
| 20-Day Raw Stochastic | 18.46% | 95.24% | 26.06% | ||
| 20-Day Relative Strength | 52.09 | 87.56 | 50.33 | ||
| Weighted Alpha | +35.20 | +35.05 | -4.66 | ||
| Today's Opinion | N/A | 100% Buy | 80% Buy | ||
| Yesterday's Opinion | N/A | 100% Buy | 80% Buy | ||
| Last Month's Opinion | N/A | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.92% since 07/06/18 | +0.20% since 08/24/26 | -7.60% since 08/26/26 | ||
| Low | 23.02 on 07/09/18 | 84.78 on 08/25/26 | 20.63 on 09/01/26 | ||
| High | 24.43 on 07/13/18 | 85.01 on 08/31/26 | 22.64 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | -12.88% since 06/13/18 | +1.71% since 07/31/26 | +4.18% since 07/31/26 | ||
| Low | 22.56 on 06/28/18 | 83.62 on 08/03/26 | 19.00 on 08/04/26 | ||
| High | 27.25 on 06/14/18 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| 3-Month | |||||
| %Chg | +36.44% since 04/13/18 | +138.96% since 05/29/26 | +10.06% since 06/02/26 | ||
| Low | 16.76 on 04/16/18 | 32.30 on 06/02/26 | 16.27 on 06/16/26 | ||
| High | 27.79 on 06/13/18 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| 6-Month | |||||
| %Chg | -1.85% since 01/12/18 | +106.69% since 02/27/26 | +37.04% since 03/02/26 | ||
| Low | 14.44 on 03/02/18 | 32.30 on 06/02/26 | 12.89 on 03/27/26 | ||
| High | 27.79 on 06/13/18 | 85.01 on 08/31/26 | 23.18 on 08/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,159,814 | 9,010,222 | 6,271,878 | ||
| Shares Outstanding, K | 348,710 | 106,065 | 302,843 | ||
| Annual Sales, $M | 8,724,000,000 | 7,700,000 | 1,342,160,000 | ||
| Annual Net Income, $M | 2,404,000,000 | -465,320,000 | 158,210,000 | ||
| Last Qtr Sales, $M | 1,995,000,000 | 25,120,000 | 351,140,000 | ||
| Last Qtr Income, $M | -2,693,000,000 | -120,860,000 | 26,690,000 | ||
| 60-Month Beta | -0.38 | 0.12 | 0.74 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.89 on 05/08/18 | -1.14 on 08/03/26 | 0.16 on 08/04/26 | ||
| Latest Earnings Date | 08/14/18 | 11/05/26 | 11/05/26 | ||
| Most Recent Dividend | 1.000 on 11/10/10 | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 6.12 | 0.00 | 32.47 | ||